Laddar...
Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report
BACKGROUND: Patients undergone kidney transplantation present higher risk of Urothelial Carcinoma (UC) development and represent a subgroup of special interest. To date, vinflunine is the only drug approved in Europe for the treatment of advanced UC after failure of platinum-based chemotherapy. Howe...
Sparad:
| I publikationen: | BMC Cancer |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4983020/ https://ncbi.nlm.nih.gov/pubmed/27519420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2666-6 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|